Northside Capital Management’s Zimmer Biomet ZBH Stock Holding History

Northside Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4M	Sell	132,214 -3,449	-3%	-$302K	0.93%	33
2026 Q1	$12.3M	Sell	135,663 -4,563	-3%	-$419K	1.08%	28
2025 Q4	$12.6M	Buy	140,226 +82,844	+144%	+$7.86M	1.1%	30
2025 Q3	$5.65M	Buy	57,382 +20	+0%	+$1.98K	0.52%	47
2025 Q2	$5.23M	Buy	+57,362	New	+$5.55M	0.4%	44

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Northside Capital Management's ZBH Position: Q2 2026 in Review

Northside Capital Management reduced its Zimmer Biomet (ZBH) stake by 2.5% in Q2 2026, selling an estimated $302K and leaving 132,214 shares worth $11.4M. The position accounts for 0.93% of the portfolio, ranked #33.

Northside Capital Management first reported a position in ZBH in Q2 2025 and has held it in 5 quarters since. The position peaked at $12.6M in Q4 2025. 113 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Northside Capital Management held 132,214 shares of Zimmer Biomet worth $11.4M as of Q2 2026.
Northside Capital Management sold 3,449 Zimmer Biomet shares in Q2 2026, an estimated $302K.
Zimmer Biomet made up 0.93% of Northside Capital Management's portfolio in Q2 2026, its #33 holding.
Northside Capital Management first reported a position in Zimmer Biomet in Q2 2025 and has held it in 5 quarters since.
Northside Capital Management's Zimmer Biomet position peaked at $12.6M in Q4 2025.
113 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Northside Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.